The familial incidences of allergy and asthma suggest a genetic basis for these diseases. Recently, genome-wide searches and candidate gene approaches have been used to examine the possible involvement of a number of genes in the development of atopy and asthma. The regions of potential linkage to markers were detected with one or more asthma phenotypes on chromosomes 5q, 6p, 11q, 12q, 13q, and 14q, respectively (1-3).Human leukocyte antigen (HLA) molecules are encoded by highly polymorphic gene families located on chromosome 6p. They play a pivotal role in regulating the T-cell immune response and have been implicated in susceptibility to a wide range of diseases with an immunologic basis. The association of HLA haplotypes and ragweed allergy was the first human Ir (immune response) gene to be recognized (4), and HLA-DR2 and HLA-DQ6 restriction of IgE reactions to antigen 5 is well documented (5-7). Recently, strong relationships between the immune response to several highly purified allergens and specific HLA-DR and DQ haplotypes have been published (reviewed in ref. 8). In addition, specific HLA-DR and DQ molecules have been shown to be implicated in house dust mite asthma (9, 10), aspirin-induced asthma (11), soybean epidemic asthma (12), and occupational asthma and atopy involving isocyanates (13) or acid anhydrides (14). However, the role and contribution of specific HLA class II molecules in the development of allergic asthma are unknown and are difficult to assess in humans because of their genetic heterogeneity.Eosinophils play an important role in the pathogenesis of allergic airway inflammation. The infiltration of the airway wall with a large number of activated eosinophils and release of their toxic granule proteins and lipid metabolites cause damage to bronchial epithelial cells (15)(16)(17)(18)(19). It is believed that an airway hyperresponsiveness, the hallmark of asthma, occurs as a result of this eosinophil-mediated damage. In the majority of clinical studies, pulmonary eosinophilia has been shown to correlate with disease severity (15,17), and the resolution of airway eosinophilia correlates with the remission of asthma symptoms (16).Recently, a number of murine models of antigeninduced pulmonary eosinophilia and airway hyperreactivity (AHR) have been developed to study the role of B cells (20,21), T cells (20,(22)(23)(24), mast cells (25), NK cells (20), dendritic cells (26), IgE and its receptor (27, 28), cytokines (29-32), leukotrienes (33), and costimulatory molecules (34,35) in the mechanisms of immune responses in asthma. However, in all of these animal models, MHC class II molecules are mouse derived. We have generated transgenic mice expressing human DQ6 (HLA-DQA1*0103 and HLA-DQB1*0601) and DQ8 (HLA-DQA1*0301 and HLA-DQB1*0302) genes (36-38). These mice lack endogenous class II molecules, and the only functional class II molecules on antigen-presenting cells (APCs) are human DQ6 or DQ8. The human leukocyte antigen (HLA) restriction of the IgE response to different allergens in humans ...